WallStreetZenWallStreetZen

NASDAQ: TCON
Tracon Pharmaceuticals Inc Stock Ownership - Who owns Tracon Pharmaceuticals?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Tracon Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Opaleye Management Inc10% Owner2023-11-10440,000$0.29
$129.36kSell
Opaleye Management Inc10% Owner2023-11-104,324,008$0.29
$1.27MSell
Charles TheuerPRESIDENT AND CEO2023-10-203,500$0.13
$465.50Buy
Charles TheuerPresident and CEO2023-04-2747,000$0.75
$35.25kBuy

1 of 1

TCON insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TCON insiders and whales buy or sell their stock.

TCON Shareholders

What type of owners hold Tracon Pharmaceuticals Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Peter J. Barris273.56%6,224,042$11.76MInsider
Peter W. Sonsini273.56%6,224,042$11.76MInsider
Ravi Viswanathan273.56%6,224,042$11.76MInsider
Forest Baskett273.56%6,224,042$11.76MInsider
Scott D. Sandell273.56%6,224,042$11.76MInsider
M. James Barrett273.56%6,224,042$11.76MInsider
David M. Mott273.56%6,224,042$11.76MInsider
Anthony A. Florence Jr.273.56%6,224,042$11.76MInsider
Patrick J. Kerins273.56%6,224,042$11.76MInsider
Krishna Kittu Kolluri204.22%4,646,513$8.78MInsider

1 of 3

TCON vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TCON6.34%93.66%Net Selling
GNPX48.09%51.91%Net SellingNet Selling
ENSC0.72%57.99%
LGVN14.25%85.75%Net BuyingNet Buying
CING0.05%99.95%Net BuyingNet Buying
View Top Biotech Stocks

Tracon Pharmaceuticals Stock Ownership FAQ

Who owns Tracon Pharmaceuticals?

Tracon Pharmaceuticals (NASDAQ: TCON) is owned by 226.95% institutional shareholders, 3,351.15% Tracon Pharmaceuticals insiders, and 0.00% retail investors. Peter J. Barris is the largest individual Tracon Pharmaceuticals shareholder, owning 6.22M shares representing 273.56% of the company. Peter J. Barris's Tracon Pharmaceuticals shares are currently valued at $11.14M.

If you're new to stock investing, here's how to buy Tracon Pharmaceuticals stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.